Regeneron Pharmaceuticals research and development expenses for the twelve months ending December 31, 2024 were $5.132B, a 15.61% increase year-over-year.
Regeneron Pharmaceuticals annual research and development expenses for 2024 were $5.132B, a 15.61% increase from 2023.
Regeneron Pharmaceuticals annual research and development expenses for 2023 were $4.439B, a 23.56% increase from 2022.
Regeneron Pharmaceuticals annual research and development expenses for 2022 were $3.593B, a 25.61% increase from 2021.
Regeneron Pharmaceuticals Research and Development Expenses 2010-2024 | REGN